Xeris Biopharma Holdings Future Growth
How is Xeris Biopharma Holdings forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XERS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: XERS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: XERS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: XERS's revenue (26.6% per year) is forecast to grow faster than the US market (6.9% per year).
High Growth Revenue: XERS's revenue (26.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if XERS's Return on Equity is forecast to be high in 3 years time